The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

Chen Yan; Chu Fuhao; Lin Jie; Su Zeqi; Liao Mengting; Li Tao; Li Yuan; Johnson Nadia; Zheng Haocheng; Ding Xia

首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

【24h】

The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

机译：使用网络药理学方法和体内研究，伟昌安药丸（WCAP）治疗腹泻优势肠易激综合征（IBS-D）的作用机制

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Ethnopharmacological relevance: WeiChang'An Pill (WCAP) is used in Traditional Chinese Medicine (TCM) to clinically treat diarrhoea-predominant irritable bowel syndrome (IBS-D); however, the underlying pharmacological mechanisms are unclear to date.

机译：民族药理学相关性：胃肠安丸（WCAP）用于中医临床治疗腹泻型肠易激综合征（IBS-D）；然而，到目前为止，潜在的药理机制尚不清楚。

著录项

来源
《Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs》 |2021年第1期|共11页
作者
Chen Yan; Chu Fuhao; Lin Jie; Su Zeqi; Liao Mengting; Li Tao; Li Yuan; Johnson Nadia; Zheng Haocheng; Ding Xia;
展开▼
作者单位

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

Beijing Univ Chinese Med Sch Tradit Chinese Med Beijing Peoples R China;

Beijing Univ Chinese Med Sch Tradit Chinese Med Beijing Peoples R China;

Beijing Univ Chinese Med Beijing Res Inst Chinese Med Beijing Peoples R China;

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

Beijing Univ Chinese Med Sch Tradit Chinese Med Beijing Peoples R China;

Beijing Univ Chinese Med Dongzhimen Hosp Beijing Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
WeiChang'An Pill (WCAP); Diarrhoea-predominant irritable bowel syndrome (IBS-D); Network pharmacology; Mechanism; cAMP signalling pathway;

机译：weichang'an丸（WCAP）;腹泻主要肠易激综合征（IBS-D）;网络药理学;机制;营地信号通路;

相似文献

外文文献
中文文献
专利

1. Mechanism of Cangfu Daotan pill in treating polycystic ovary syndrome based on network pharmacology [J] . Pan-Wei Hu, Jia Li, Dan Liu, 海南医科大学学报（英文版） . 2021,第012期
2. Mechanism of Cangfu Daotan pill in treating polycystic ovary syndrome based on network pharmacology [J] . Pan-Wei Hu, Jia Li, Dan Liu, 海南医科大学学报(英文版) . 2021,第012期
3. A network pharmacology approach to explore action mechanisms of Bi xie and Tu fuling for treating gouty arthritis [J] . Zi-Xing Bai, Xu-Han Cao, Cheng-Yi Sun, 海南医科大学学报（英文版） . 2020,第008期
4. A network pharmacology approach to explore action mechanisms of Si Miao decoction for treating acute gouty arthritis [J] . Zi-Xing Bai, Xu-Han Cao, Cheng-Yi Sun, 海南医科大学学报（英文版） . 2020,第020期
5. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial [J] . Matthew P Leighton, Ching Lam, Samir Mehta, Trials . 2013,第1期

机译：美沙拉嗪治疗腹泻型肠易激综合征（IBS-D）的功效和作用方式：一项随机对照试验的研究方案
6. A pilot study of the effect of mindfulness-based stress reduction on clinical symptoms and immune response of patients with diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [J] . Neurogastroenterology and motility . 2019,第S4期

机译：一种试点研究腹泻患者腹泻优势肠综合征患者临床症状和免疫应答的试验研究（IBS-D）
7. MAPPING THE IRRITABLE BOWEL SYNDROME QUALITY OF LIFE MEASURE (IBS-QOL) TO EQ-5D IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA (IBS-D) [J] . Bjorner J. B., Rendas-Baum R., Carson R. T., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：将肠易激综合征（IBS-D）患者的肠易激综合征的生活质量（IBS-QOL）映射到EQ-5D
8. The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [C] . Xiaojie Ding, Xiling Sun, Xiaofei Yu, International Conference on Biotechnology and Bioengineering . 2019

机译：尿布丸对腹泻的肠道菌群和神经递质的影响（IBS-D）
9. Molecular Mechanisms in Irritable Bowel Syndrome [D] . Videlock, Elizabeth Jane. 2019

机译：肠易激综合征的分子机制
10. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial [O] . Matthew P Leighton, Ching Lam, Samir Mehta, 2013

机译：美沙拉嗪治疗腹泻型肠易激综合征（IBS-D）的功效和作用方式：一项随机对照试验的研究方案
11. Study on the Mechanism of Tiaogan Yunpi Decoction in Treating Diarrhea-Irritable Bowel Syndrome Based on Network Pharmacology [O] . Jing Yan, Fei Ge, Zhi-wei Miao, 2020

机译：基于网络药理学治疗腹泻肠辨证治疗腹泻肠综合征的机制研究
12. Novel siRNA-Based Approach to Study Mechanisms of Resistance/Action of a New Drug in Treatment of Breast Cancer. Addendum [R] . Bertino, J. R. , Krouse-Mandola, J. , Budak-Alpdogan, T. , 2006

机译：基于siRNa的新方法研究新药治疗乳腺癌的耐药性/作用机制。附录

The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

摘要

著录项

相似文献

相关主题

期刊订阅